Potential for primary prevention of Alzheimer's disease: an analysis of population-based data

被引:24
作者
Norton, Sam [1 ]
Matthews, Fiona E. [2 ]
Barnes, Deborah E. [3 ,4 ,6 ]
Yaffe, Kristine [3 ,4 ,5 ,6 ]
Brayne, Carol [7 ]
机构
[1] Kings Coll London, Inst Psychiat, Dept Psychol, London, England
[2] Inst Publ Hlth, Med Res Council Biostat, Cambridge, England
[3] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[6] San Francisco VA Med Ctr, San Francisco, CA USA
[7] Univ Cambridge, Inst Publ Hlth, Cambridge CB2 0SR, England
关键词
PUBLIC-HEALTH IMPACT; RISK-FACTOR; COGNITIVE FUNCTION; UNITED-STATES; DEMENTIA; PREVALENCE; METAANALYSIS; PROJECTIONS; DEPRESSION;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Recent estimates suggesting that over half of Alzheimer's disease burden worldwide might be attributed to potentially modifiable risk factors do not take into account risk-factor non-independence. We aimed to provide specific estimates of preventive potential by accounting for the association between risk factors. Methods Using relative risks from existing meta-analyses, we estimated the population-attributable risk (PAR) of Alzheimer's disease worldwide and in the USA, Europe, and the UK for seven potentially modifiable risk factors that have consistent evidence of an association with the disease (diabetes, midlife hypertension, midlife obesity, physical inactivity, depression, smoking, and low educational attainment). The combined PAR associated with the risk factors was calculated using data from the Health Survey for England 2006 to estimate and adjust for the association between risk factors. The potential of risk factor reduction was assessed by examining the combined effect of relative reductions of 10% and 20% per decade for each of the seven risk factors on projections for Alzheimer's disease cases to 2050. Findings Worldwide, the highest estimated PAR was for low educational attainment (19.1%, 95% CI 12.3-25.6). The highest estimated PAR was for physical inactivity in the USA (21.0%, 95% CI 5.8-36.6), Europe (20.3%, 5.6-35.6), and the UK (21.8%, 6.1-37.7). Assuming independence, the combined worldwide PAR for the seven risk factors was 49.4% (95% CI 25.7-68.4), which equates to 16.8 million attributable cases (95% CI 8.7-23.2 million) of 33.9 million cases. However, after adjustment for the association between the risk factors, the estimate reduced to 28.2% (95% CI 14.2-41.5), which equates to 9.6 million attributable cases (95% CI 4.8-14.1 million) of 33.9 million cases. Combined PAR estimates were about 30% for the USA, Europe, and the UK. Assuming a causal relation and intervention at the correct age for prevention, relative reductions of 10% per decade in the prevalence of each of the seven risk factors could reduce the prevalence of Alzheimer's disease in 2050 by 8.3% worldwide. Interpretation After accounting for non-independence between risk factors, around a third of Alzheimer's diseases cases worldwide might be attributable to potentially modifiable risk factors. Alzheimer's disease incidence might be reduced through improved access to education and use of effective methods targeted at reducing the prevalence of vascular risk factors (eg, physical inactivity, smoking, midlife hypertension, midlife obesity, and diabetes) and depression.
引用
收藏
页码:788 / 794
页数:7
相关论文
共 32 条
[1]  
[Anonymous], 2009, Global health risks: mortality and burden of disease attributable to selected major risks
[2]   The projected effect of risk factor reduction on Alzheimer's disease prevalence [J].
Barnes, Deborah E. ;
Yaffe, Kristine .
LANCET NEUROLOGY, 2011, 10 (09) :819-828
[3]   Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset [J].
Brookmeyer, R ;
Gray, S ;
Kawas, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1337-1342
[4]  
Brookmeyer R, 2009, INTERNET BASED FOREC
[5]   Forecasting the global burden of Alzheimer's disease [J].
Brookmeyer, Ron ;
Johnson, Elizabeth ;
Ziegler-Graham, Kathryn ;
Arrighi, H. Michael .
ALZHEIMERS & DEMENTIA, 2007, 3 (03) :186-191
[6]   Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies [J].
Cheng, G. ;
Huang, C. ;
Deng, H. ;
Wang, H. .
INTERNAL MEDICINE JOURNAL, 2012, 42 (05) :484-491
[7]   Confounding and Bias in the Attributable Fraction [J].
Darrow, Lyndsey A. ;
Steenland, N. Kyle .
EPIDEMIOLOGY, 2011, 22 (01) :53-58
[8]   National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease and Cognitive Decline [J].
Daviglus, Martha L. ;
Bell, Carl C. ;
Berrettini, Wade ;
Bowen, Phyllis E. ;
Connolly, E. Sander, Jr. ;
Cox, Nancy Jean ;
Dunbar-Jacob, Jacqueline M. ;
Granieri, Evelyn C. ;
Hunt, Gail ;
McGarry, Kathleen ;
Patel, Dinesh ;
Potosky, Arnold L. ;
Sanders-Bush, Elaine ;
Silberberg, Donald ;
Trevisan, Maurizio .
ANNALS OF INTERNAL MEDICINE, 2010, 153 (03) :176-U72
[9]   Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies [J].
Diniz, Breno S. ;
Butters, Meryl A. ;
Albert, Steven M. ;
Dew, Mary Amanda ;
Reynolds, Charles F., III .
BRITISH JOURNAL OF PSYCHIATRY, 2013, 202 (05) :329-335
[10]   Global prevalence of dementia: a Delphi consensus study [J].
Ferri, CP ;
Prince, M ;
Brayne, C ;
Brodaty, H ;
Fratiglioni, L ;
Ganguli, M ;
Hall, K ;
Hasegawa, K ;
Hendrie, H ;
Huang, YQ ;
Jorm, A ;
Mathers, C ;
Menezes, PR ;
Rimmer, E ;
Scazufca, M .
LANCET, 2005, 366 (9503) :2112-2117